SurvivalNet: Predicting patient survival from diffusion weighted
  magnetic resonance images using cascaded fully convolutional and 3D
  convolutional neural networks by Christ, Patrick Ferdinand et al.
SURVIVALNET: PREDICTING PATIENT SURVIVAL FROM DIFFUSIONWEIGHTED
MAGNETIC RESONANCE IMAGES USING CASCADED FULLY CONVOLUTIONAL AND 3D
CONVOLUTIONAL NEURAL NETWORKS
Patrick Ferdinand Christ 1,? Florian Ettlinger1,? Georgios Kaissis1,†
Sebastian Schlecht? Freba Ahmaddy† Felix Gru¨n? Alexander Valentinitsch†
Seyed-Ahmad Ahmadi+ Rickmer Braren2,† Bjoern Menze2,?
? Technische Universita¨t Mu¨nchen, Image-Based Biomedical Modeling Group, Arccisstrasse 21, 80333 Munich
†Technische Universita¨t Mu¨nchen, Institute for diagnostic and interventional Radiology, Ismaninger Str. 22, 81675 Munich
+ Ludwig-Maximilians-Universita¨t, German Center for Vertigo and Balance Disorders, Feodor-Lynen-Straße 19, 81377 Munich
ABSTRACT
Automatic non-invasive assessment of hepatocellular carci-
noma (HCC) malignancy has the potential to substantially en-
hance tumor treatment strategies for HCC patients. In this
work we present a novel framework to automatically charac-
terize the malignancy of HCC lesions from DWI images.
We predict HCC malignancy in two steps: As a first step
we automatically segment HCC tumor lesions using cascaded
fully convolutional neural networks (CFCN). A 3D neural
network (SurvivalNet) then predicts the HCC lesions’ ma-
lignancy from the HCC tumor segmentation. We formulate
this task as a classification problem with classes being “low
risk” and “high risk” represented by longer or shorter survival
times than the median survival. We evaluated our method on
DWI of 31 HCC patients. Our proposed framework achieves
an end-to-end accuracy of 65% with a Dice score for the au-
tomatic lesion segmentation of 69% and an accuracy of 68%
for tumor malignancy classification based on expert annota-
tions. We compared the SurvivalNet to classical handcrafted
features such as Histogram and Haralick and show experi-
mentally that SurvivalNet outperforms the handcrafted fea-
tures in HCC malignancy classification. End-to-end assess-
ment of tumor malignancy based on our proposed fully auto-
matic framework corresponds to assessment based on expert
annotations with high significance (p > 0.95).
Index Terms— Survival Prediction, 3D Neural Network,
Fully Convolutional Neural Networks, MRI
1. INTRODUCTION
1.1. Motivation
Hepatocellular carcinoma (HCC) presents the sixth most
common cancer and the third most common cause of cancer-
related deaths worldwide [1]. HCC comprises a genetically
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and molecularly highly heterogeneous group of cancers that
commonly arise in a chronically damaged liver. Importantly,
HCC subtypes differ significantly in clinical outcome. The
stepwise transformation to HCC is accompanied by major
changes in tissue architecture including an increase in cellu-
larity and a switch in vascular supply (i.e. arterialization).
These differences provide the basis for the non-invasive
detection of HCC [2]. In particular, diffusion weighted-
magnetic resonance imaging (DW-MRI) detects differences
in random Brownian motion, which is commonly reduced in
highly cellular HCC due to an increase in cell membranes and
macromolecules. The apparent diffusion coefficient (ADC)
parameter value, which can be derived from two DW-MRI
scans, quantifies this effect. DW-MRI imaging techniques
provide a high level of sensitivity and specificity for tu-
mor detection, the distinction of tumor subtypes requires the
identification of more subtle differences. Computer aided
analysis techniques allow medical image feature extraction
far beyond the capabilities of the human eye and thus hold
the potential for an imaging based differentiation of tumor
subtypes. Non-invasive differentiation of tumor subtypes in
HCC would enable pre-therapeutic patient stratification and
the systematic testing of novel therapeutic strategies.
1.2. Related Works
Heid et al. (2016) have recently established a close rela-
tionship between the regional DW-MRI derived apparent dif-
fusion coefficient (ADC) parameter value and distinct sub-
types in pancreatic ductal adenocarcinoma (PDAC) [3]. Com-
puter aided extraction of image features for tumor subtyping
has previously been reported for several tumor entities. Prior
work focused mostly on hand-crafted feature extraction such
as histogram features [4], Gabor and Haralick features [5, 6],
and grey level run length based features [7] to predict sur-
vival times for diverse tumor entities and image modalities.
Recent works leveraged the discriminative power of the ap-
parent diffusion coefficient (ADC) by extracting texture fea-
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Fig. 1. Results of the automatic HCC tumor segmentation in DW-MRI: A and C show the DW-MRI slice. B and D show
the ground truth label of HCC in green and the automatic segmentation using CFCN in blue. The automatic segmentation
algorithms successfully segments the HCC tumor in both cases. Only two small false-positive regions and a slight inaccuracy
around the edges of the tumors are visible leading to a Dice overlap score of 85 % for B and 83 % for D. The patient in A/B
belongs to class “high risk” whereas C/D belongs to class “low risk”. Yet, only subtle overall differences in appearance between
the tumors are visible.
tures for survival or malignancy characterization [8, 9]. Zhou
et al. (2016) proposed a method to characterize malignancy of
HCC in contrast enhanced MRI by extracting histogram and
texture based features such as grey-level co-occurrence and
run length (GLRL and GLCM) of HCC lesions [10]. How-
ever, their method required manual segmentation of the le-
sions beforehand.
1.3. Contribution
In comparison to prior work, we developed a method to pre-
dict HCC survival from DW-MRI volumes using automatic
segmentations of tumors. Our contribution in this work is
three-fold. First, we developed an automatic method to de-
tect and segment HCC tumor lesions in DW-MRI data. Sec-
ond, we found and analyzed quantitative biomarkers using
handcrafted and CNN-based features to predict patient sur-
vival. Third, we experimentally demonstrated a fully auto-
matic method to predict long/short survival of HCC patients
from DW-MRI images.
2. METHODS
Our proposed framework to fully automatically predict
short/long survival from DW-MRI of HCC patients is de-
picted in figure 3.
2.1. Dataset
31 Patients underwent clinical assessment and MR imaging
for the primary diagnosis of HCC. Barcelona Clinic Liver
Cancer Classification was used to assess the clinical stage of
the disease. Patients with a history of prior malignancy were
excluded. No data with insufficient quality due to breath-
ing artifacts, excessive banding or distortion, diffuse tumor
growth or non-detectability of the lesions in the DW-MRI se-
quences was included in the dataset. Imaging was performed
using a 1.5 T clinical MRI scanner (Avanto, Siemens) with
a standard imaging protocol including axial and coronal T2w,
axial T1w images before and after application of Gadolinium-
DTPA contrast agent (Jenapharm Magnograf 0.5 mmol/ml
per manufacturers instructions). Post-contrast T1w images
were acquired in the early, mid and late arterial phases as well
as in the portal venous phase. Diffusion weighted imaging
was performed using a slice thickness of 5mm and a matrix
size of 192 by 192. Institutional review board approval was
obtained for this retrospective study.
2.2. Automatic Segmentation
To automatically detect and segment tumor lesions we applied
a cascaded fully convolutional neural network to segment in
step 1 the liver and in a step 2 the tumor lesions from a liver
ROI volume [11]. We used the DW-MRI as input to the FCN
architecture proposed by Ronneberger et al. (2015) [12]. We
fine-tuned our networks using the liver and liver tumor model
provided by Christ et al. (2016) [11] and applied a 5-fold
cross-validation. Tumor margins were identified in the early
arterial phase and in DWI images (b=600). Manual segmen-
tation was performed by an experienced radiologist using the
software TurtleSeg R© and reviewed by two expert radiologists.
2.3. Survival Prediction
To predict the survival rate of HCC tumor patients we cal-
culated different features using the detected and segmented
tumor lesions applied in the ADC image sequences. We cal-
culated handcrafted features and features trained end-to-end
by a 3D Convolutional Neural Network (SurvivalNet).
2.3.1. Handcrafted Features
ADC value histograms were generated from the regions of
the ADC map corresponding to the tumor ROI in the b=600
image. Histogram descriptors were obtained including mean,
Fig. 2. Kaplan-Meier Survival Analysis for Haralick Features (left), Histogram Features (middle) and 3D SurvivalNet CNN
(right). The SurvivalNet is able to split the HCC patients into high risk i.e. short survival and low risk i.e. long survival. In
contrast, classical handcrafted features such as histogram and Haralick do not predict the patient survival correctly. GT stands
for ground truth.
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Fig. 3. Framework for lesion segmentation and survival pre-
diction
median, kurtosis and skewness. In addition, we extracted fea-
tures representing ADC texture by calculating 3D Haralick
statistics of the grey-level co-occurrence matrix [13]. We
trained a k-nearest-neighbour classifier with k=4 and vali-
dated the results using 10-fold cross-validation.
2.3.2. SurvivalNet: 3D Convolutional Neural Network
Finally, we trained a 3D CNN to predict the survival rate in an
end-to-end fashion. The SurvivalNet consists of two stacks of
3D convolution and max pooling layers, followed by 2 fully-
connected layers. The 3D convolutions have 50 kernels with
a kernel size of 3x3x3 pixels and a 3D spatial dropout with
p = 0.3. The first fully-connected layer has 500 neurons.
Figure 4 shows the SurvivalNet architecture. We trained the
SurvivalNet from scratch using the Adadelta gradient-descent
algorithm [14] at a learning rate of 0.5, ρ = 0.95 and  =
1 · 10−8. We employed no data-augmentation.
Table 2 shows the performance of the handcrafted features
and SurvivalNet.
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Fig. 4. The SurvivalNet is a 3D CNN that consists of two
blocks of 3D convolution followed by 3D maxpooling and
finally two fully connected layers.
3. RESULTS
3.1. Qualitative
The qualitative results of the automatic segmentation are de-
picted in figure 1. The complex and heterogeneous shape of
the tumor lesions was detected and segmented in both im-
ages using our automatic segmentation algorithm. The trained
model achieves a Dice overlap score of 85% in both images.
The segmentation reaches a high level of specificity by clas-
sifying all lesion pixels in the image as lesions. Small false
positive outliers within the liver reduce the overall accuracy
and Dice score.
3.2. Quantitative
The quantitative results for our automatic segmentation
method are shown in table 1. Our automatic HCC lesion seg-
mentation algorithm achieves a Dice overlap score of 69.7%
trained on DW-MRI images. The trained model is highly
sensitive in recognizing HCC lesions with a Sensitivity of
Table 1. Quantitative tumor segmentation results
Method Sensitivity Precision TNR RVD Dice
[%] [%] [%] [%] [%]
Cascaded FCN on DWI 91.1 70.0 99.6 52.1 69.7
Table 2. Survival prediction results using both manual tumor
segmentations and the output of the automatic tumor segmen-
tation as inputs for the survival prediction classifier
Features ACC Precision Sensitivity F1-Score[%] [%] [%] [%]
Manual Tumor Seg.
SurvivalNet CNN 68 69 68 65
Histogram Features 61 62 61 60
Texture Features: 3D Haralick 61 65 61 58
Automatic Tumor Seg.
SurvivalNet CNN 65 64 65 64
Histogram Features 58 59 58 56
Texture Features: 3D Haralick 61 62 62 60
91.1%, i.e. only few false negative errors occur.
Table 2 shows the quantitative results of our proposed
automatic survival prediction framework. Figure 2 shows a
Kaplan-Meier plot of the survival prediction results. Sur-
vivalNet achieves higher scores on both manual and auto-
matic segmentation compared to handcrafted features. Sur-
vivalNet trained on manual segmentations achieves an accu-
racy of 68% with a Precision and Sensitivity of 69% and 68%
respectively. Furthermore, SurvivalNet accomplishes a clas-
sification accuracy of 65% at a Precision and Sensitivity of
64% and 65% when trained using our automatic tumor seg-
mentation in a fully automatic fashion.
As a final experiment, we calculated a paired Wilcoxon
signed-rank test with H0: the output posterior class probabil-
ities of SurvivalNet with manual and automatic segmentation
belong to the same distribution. At p > 0.953, we found H0
to be confirmed, i.e. SurvivalNet produces the same results
with automatic segmentation or manual segmentation.
4. CONCLUSION AND DISCUSSION
The predictive value of various imaging parameters has pre-
viously been suggested in HCC. With the growing appre-
ciation of tumor heterogeneity as a major obstacle to treat-
ment response, more sophisticated image analysis algorithms
are required. The complexity of such data analyses, espe-
cially considering multi-parametric multimodality imaging,
requires computer aided techniques. We have presented a
fully automatic framework to predict survival times of HCC
patients. This approach based on fully convolutional and 3D
convolutional neural networks outperformed state-of-the art
handcrafted features, while still achieving the same diagnos-
tic outcome as if human expert segmentations were provided.
This work may have potential applications in HCC treatment
planning.
5. ACKNOWLEDGEMENT
This work was supported by the German Research Founda-
tion (DFG) within the SFB-Initiative 824 (collaborative re-
search center), “Imaging for Selection, Monitoring and Indi-
vidualization of Cancer Therapies” (SFB824, project C6) and
the BMBF project Softwarecampus. We thank NVIDIA and
Amazon AWS for granting GPU and computation support.
6. REFERENCES
[1] Jacques Ferlay, Hai-Rim Shin, Freddie Bray, David For-
man, Colin Mathers, and Donald Maxwell Parkin, “Es-
timates of worldwide burden of cancer in 2008: Globo-
can 2008,” International Journal of Cancer, vol. 127,
no. 12, pp. 2893–2917, 2010.
[2] European Association For The Study Of The Liver,
“Easl–eortc clinical practice guidelines: management of
hepatocellular carcinoma,” Journal of Hepatology, vol.
56, no. 4, pp. 908–943, 2012.
[3] Irina Heid, Katja Steiger, Marija Trajkovic-Arsic,
Marcus Settles, Manuela R Eßwein, Mert Erkan,
Jorg Kleeff, Carsten Ja¨ger, Helmut Friess, Bernhard
Haller, Andreas Steingo¨tter, Roland M Schmid, Markus
Schwaiger, Ernst J Rummeny, Irene Esposito, Jens T
Siveke, and Rickmer Braren, “Co-clinical assessment
of tumor cellularity in pancreatic cancer,” Clinical Can-
cer Research, 2016.
[4] Sang Ho Lee, Koichi Hayano, Dushyant V. Sahani, An-
drew X. Zhu, and Hiroyuki Yoshida, “Kinetic textu-
ral biomarker for predicting survival of patients with
advanced hepatocellular carcinoma after antiangiogenic
therapy by use of baseline first-pass perfusion ct,” in
Abdominal Imaging. Computational and Clinical Appli-
cations: 6th International Workshop, ABDI 2014, Held
in Conjunction with MICCAI, pp. 48–61. 2014.
[5] Jiawen Yao, Sheng Wang, Xinliang Zhu, and Junzhou
Huang, “Imaging biomarker discovery for lung cancer
survival prediction,” in MICCAI, pp. 649–657. 2016.
[6] X. Zhu, J. Yao, X. Luo, G. Xiao, Y. Xie, A. Gazdar, and
J. Huang, “Lung cancer survival prediction from patho-
logical images and genetic data; an integration study,”
in IEEE ISBI, 2016, pp. 1173–1176.
[7] J. Song, D. Dong, Y. Huang, Z. Liu, and J. Tian, “As-
sociation between tumor heterogeneity and overall sur-
vival in patients with non-small cell lung cancer,” in
IEEE ISBI, 2016, pp. 1249–1252.
[8] Islam Reda, Ahmed Shalaby, Mohammed Elmogy,
Ahmed Aboulfotouh, Fahmi Khalifa, Mohamed Abou
El-Ghar, Georgy Gimelfarb, and Ayman El-Baz,
“Image-based computer-aided diagnostic system for
early diagnosis of prostate cancer,” in MICCAI, pp. 610–
618. 2016.
[9] M. Shehata, F. Khalifa, A. Soliman, M. Abou El-Ghar,
A. Dwyer, G. Gimel’farb, R. Keynton, and A. El-Baz,
“A promising non-invasive cad system for kidney func-
tion assessment,” in MICCAI, pp. 613–621. 2016.
[10] Wu Zhou, Lijuan Zhang, Kaixin Wang, Shuting Chen,
Guangyi Wang, Zaiyi Liu, and Changhong Liang, “Ma-
lignancy characterization of hepatocellular carcinomas
based on texture analysis of contrast-enhanced mr im-
ages,” Journal of Magnetic Resonance Imaging, 2016.
[11] Patrick Ferdinand Christ, Mohamed Ezzeldin A.
Elshaer, Florian Ettlinger, Sunil Tatavarty, Marc Bickel,
Patrick Bilic, Markus Rempfler, Marco Armbruster, Fe-
lix Hofmann, Melvin D’Anastasi, Wieland H. Sommer,
Seyed-Ahmad Ahmadi, and Bjoern H. Menze, “Auto-
matic liver and lesion segmentation in ct using cascaded
fully convolutional neural networks and 3d conditional
random fields,” in MICCAI, pp. 415–423. 2016.
[12] O. Ronneberger, P. Fischer, and T. Brox, “U-net: Convo-
lutional networks for biomedical image segmentation,”
in MICCAI, vol. 9351, pp. 234–241. 2015.
[13] R. M. Haralick, “Statistical and structural approaches
to texture,” Proceedings of the IEEE, vol. 67, no. 5, pp.
786–804, May 1979.
[14] Matthew D. Zeiler, “ADADELTA: an adaptive learning
rate method,” CoRR, vol. abs/1212.5701, 2012.
